Replies to post #94216 on $heff's $tation of $tocks & $olid DD

[$heff]

$MRNS..$1.26..Two failed trials in a row is crushing their stock price.

Marinus reports primary endpoint not met in Phase 2 Fragile X Syndrome trial $MRNS: Full Story http://bit.ly/29k3sjs